{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:11:15Z","timestamp":1790478675937,"version":"4.1.0"},"reference-count":78,"publisher":"Rockefeller University Press","issue":"11","license":[{"start":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T00:00:00Z","timestamp":1568073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.rupress.org\/terms\/"},{"start":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T00:00:00Z","timestamp":1588550400000},"content-version":"vor","delay-in-days":237,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"funder":[{"name":"Engles Fund for TSC and LAM"},{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Orphan Disease Center"},{"DOI":"10.13039\/10.13039\/100005963","name":"LAM Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/10.13039\/100005963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["DOD-W81XWH-18-1-0592"],"award-info":[{"award-number":["DOD-W81XWH-18-1-0592"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["DOD-17-1-0205"],"award-info":[{"award-number":["DOD-17-1-0205"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1P01CA120964"],"award-info":[{"award-number":["1P01CA120964"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rupress.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,11,4]]},"abstract":"<jats:p>Tuberous sclerosis complex (TSC) is characterized by tumor development in the brain, heart, kidney, and lungs. In TSC tumors, loss of the TSC1\/TSC2 protein complex leads to activation of mTORC1 with downstream effects on anabolism and cell growth. Because mTORC1 activation enhances mRNA transcription, we hypothesized that aberrant mTORC1 activation might confer TSC-null cell dependence on transcriptional regulation. We demonstrate that TSC1- or TSC2-null cells, in contrast to their wild-type counterparts, are sensitive to pharmacological inhibition of CDK7. Mechanistic studies revealed that CDK7 inhibition markedly reduces glutathione levels and increases reactive oxygen species due to reduced expression of NRF2 and glutathione biosynthesis genes. Treatment of both Tsc2+\/\u2212 mice and a TSC1-null bladder cancer xenograft model with a CDK7 inhibitor showed marked reduction in tumor volume and absence of regrowth in the xenograft model. These results suggest that CDK7 inhibition is a promising therapeutic approach for treatment of TSC-associated tumors and cancers with mutations in either TSC1 or TSC2.<\/jats:p>","DOI":"10.1084\/jem.20190251","type":"journal-article","created":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T14:45:11Z","timestamp":1568126711000},"page":"2635-2652","update-policy":"https:\/\/doi.org\/10.1084\/jem.crossmarkpolicy","source":"Crossref","is-referenced-by-count":27,"title":["RETRACTED: Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion"],"prefix":"10.1084","volume":"216","author":[{"given":"Mahsa","family":"Zarei","sequence":"first","affiliation":[{"name":"Cancer Genetics Laboratory, Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA 1"},{"name":"Department of Veterinary Physiology and Pharmacology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Du","sequence":"additional","affiliation":[{"name":"Cancer Genetics Laboratory, Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8084-9105","authenticated-orcid":true,"given":"Amin H.","family":"Nassar","sequence":"additional","affiliation":[{"name":"Cancer Genetics Laboratory, Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6718-142X","authenticated-orcid":true,"given":"Rachel E.","family":"Yan","sequence":"additional","affiliation":[{"name":"Cancer Genetics Laboratory, Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krinio","family":"Giannikou","sequence":"additional","affiliation":[{"name":"Cancer Genetics Laboratory, Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha H.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Veterinary Physiology and Pharmacology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilaire C.","family":"Lam","sequence":"additional","affiliation":[{"name":"Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth P.","family":"Henske","sequence":"additional","affiliation":[{"name":"Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tinghu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 4"},{"name":"Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Asara","sequence":"additional","affiliation":[{"name":"Division of Signal Transduction, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5668-5219","authenticated-orcid":true,"given":"David J.","family":"Kwiatkowski","sequence":"additional","affiliation":[{"name":"Cancer Genetics Laboratory, Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA 1"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"291","published-online":{"date-parts":[[2019,9,10]]},"reference":[{"key":"2026061209213089900_bib1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.molcel.2009.04.016","article-title":"TFIIH kinase places bivalent marks on the carboxy-terminal domain of RNA polymerase II","volume":"34","author":"Akhtar","year":"2009","journal-title":"Mol. Cell."},{"key":"2026061209213089900_bib2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031900","article-title":"Therapeutic trial of metformin and bortezomib in a mouse model of tuberous sclerosis complex (TSC)","volume":"7","author":"Auricchio","year":"2012","journal-title":"PLoS One."},{"key":"2026061209213089900_bib3","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1126\/science.1228792","article-title":"Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1","volume":"339","author":"Ben-Sahra","year":"2013","journal-title":"Science."},{"key":"2026061209213089900_bib4","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1126\/science.aad0489","article-title":"mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle","volume":"351","author":"Ben-Sahra","year":"2016","journal-title":"Science."},{"key":"2026061209213089900_bib5","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"2026061209213089900_bib6","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","article-title":"Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"381","author":"Bissler","year":"2013","journal-title":"Lancet."},{"key":"2026061209213089900_bib7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0180939","article-title":"Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study","volume":"12","author":"Bissler","year":"2017","journal-title":"PLoS One."},{"key":"2026061209213089900_bib8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S1535-6108(03)00187-9","article-title":"TSC2 regulates VEGF through mTOR-dependent and -independent pathways","volume":"4","author":"Brugarolas","year":"2003","journal-title":"Cancer Cell."},{"key":"2026061209213089900_bib9","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1084\/jem.20081297","article-title":"TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species","volume":"205","author":"Chen","year":"2008","journal-title":"J. Exp. Med."},{"key":"2026061209213089900_bib10","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.molmed.2017.03.004","article-title":"ROS in Cancer: The Burning Question","volume":"23","author":"Chio","year":"2017","journal-title":"Trends Mol. Med."},{"key":"2026061209213089900_bib11","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.cell.2014.10.024","article-title":"CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer","volume":"159","author":"Chipumuro","year":"2014","journal-title":"Cell."},{"key":"2026061209213089900_bib12","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.molcel.2010.05.007","article-title":"Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supply","volume":"38","author":"Choo","year":"2010","journal-title":"Mol. Cell."},{"key":"2026061209213089900_bib13","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.ccell.2014.10.019","article-title":"Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor","volume":"26","author":"Christensen","year":"2014","journal-title":"Cancer Cell."},{"key":"2026061209213089900_bib14","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMra055323","article-title":"The tuberous sclerosis complex","volume":"355","author":"Crino","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"2026061209213089900_bib15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13023-017-0581-9","article-title":"Management of everolimus-associated adverse events in patients with tuberous sclerosis complex: a practical guide","volume":"12","author":"Davies","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"2026061209213089900_bib16","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.molcel.2012.06.009","article-title":"TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1","volume":"47","author":"Dibble","year":"2012","journal-title":"Mol. Cell."},{"key":"2026061209213089900_bib17","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1002\/ijc.27800","article-title":"Extrarenal perivascular epithelioid cell tumors (PEComas) respond to mTOR inhibition: clinical and molecular correlates","volume":"132","author":"Dickson","year":"2013","journal-title":"Int. J. Cancer."},{"key":"2026061209213089900_bib18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics."},{"key":"2026061209213089900_bib19","doi-asserted-by":"publisher","first-page":"6488","DOI":"10.1073\/pnas.93.13.6488","article-title":"Human cyclin-dependent kinase-activating kinase exists in three distinct complexes","volume":"93","author":"Drapkin","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2026061209213089900_bib20","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.molcel.2010.06.022","article-title":"Activation of a metabolic gene regulatory network downstream of mTOR complex 1","volume":"39","author":"D\u00fcvel","year":"2010","journal-title":"Mol. Cell."},{"key":"2026061209213089900_bib21","first-page":"5173","article-title":"Loss of Tsc1 or Tsc2 induces vascular endothelial growth factor production through mammalian target of rapamycin","volume":"63","author":"El-Hashemite","year":"2003","journal-title":"Cancer Res."},{"key":"2026061209213089900_bib22","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","article-title":"Identification and characterization of the tuberous sclerosis gene on chromosome 16","volume":"75","author":"European Chromosome 16 Tuberous Sclerosis Consortium","year":"1993","journal-title":"Cell."},{"key":"2026061209213089900_bib23","doi-asserted-by":"publisher","first-page":"C409","DOI":"10.1152\/ajpcell.00482.2002","article-title":"Regulation of PDGF production and ERK activation by estrogen is associated with TSC2 gene expression","volume":"285","author":"Finlay","year":"2003","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"2026061209213089900_bib24","doi-asserted-by":"publisher","first-page":"10881","DOI":"10.1158\/0008-5472.CAN-05-1394","article-title":"Platelet-derived growth factor-induced p42\/44 mitogen-activated protein kinase activation and cellular growth is mediated by reactive oxygen species in the absence of TSC2\/tuberin","volume":"65","author":"Finlay","year":"2005","journal-title":"Cancer Res."},{"key":"2026061209213089900_bib25","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/ana.20784","article-title":"Rapamycin causes regression of astrocytomas in tuberous sclerosis complex","volume":"59","author":"Franz","year":"2006","journal-title":"Ann. Neurol."},{"key":"2026061209213089900_bib26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","article-title":"Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial","volume":"381","author":"Franz","year":"2013","journal-title":"Lancet."},{"key":"2026061209213089900_bib27","doi-asserted-by":"publisher","first-page":"5455","DOI":"10.1128\/MCB.00637-09","article-title":"TFIIH-associated Cdk7 kinase functions in phosphorylation of C-terminal domain Ser7 residues, promoter-proximal pausing, and termination by RNA polymerase II","volume":"29","author":"Glover-Cutter","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"2026061209213089900_bib28","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nrd4002","article-title":"Modulation of oxidative stress as an anticancer strategy","volume":"12","author":"Gorrini","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"2026061209213089900_bib29","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1158\/2159-8290.CD-13-0929","article-title":"A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity","volume":"4","author":"Grabiner","year":"2014","journal-title":"Cancer Discov."},{"key":"2026061209213089900_bib30","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1158\/1541-7786.MCR-12-0605","article-title":"Equivalent benefit of rapamycin and a potent mTOR ATP-competitive inhibitor, MLN0128 (INK128), in a mouse model of tuberous sclerosis","volume":"11","author":"Guo","year":"2013","journal-title":"Mol. Cancer Res."},{"key":"2026061209213089900_bib31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/path.4176","article-title":"TSC1 involvement in bladder cancer: diverse effects and therapeutic implications","volume":"230","author":"Guo","year":"2013","journal-title":"J. Pathol."},{"key":"2026061209213089900_bib32","doi-asserted-by":"publisher","first-page":"14484","DOI":"10.1074\/jbc.273.23.14484","article-title":"Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism","volume":"273","author":"Hara","year":"1998","journal-title":"J. Biol. Chem."},{"key":"2026061209213089900_bib33","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.freeradbiomed.2008.10.040","article-title":"Nrf2-regulated glutathione recycling independent of biosynthesis is critical for cell survival during oxidative stress","volume":"46","author":"Harvey","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"2026061209213089900_bib34","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.tibs.2014.02.002","article-title":"The Nrf2 regulatory network provides an interface between redox and intermediary metabolism","volume":"39","author":"Hayes","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"2026061209213089900_bib35","doi-asserted-by":"publisher","first-page":"16035","DOI":"10.1038\/nrdp.2016.35","article-title":"Tuberous sclerosis complex","volume":"2","author":"Henske","year":"2016","journal-title":"Nat. Rev. Dis. Primers."},{"key":"2026061209213089900_bib36","doi-asserted-by":"publisher","first-page":"4104","DOI":"10.1128\/MCB.00289-08","article-title":"The TSC1-TSC2 complex is required for proper activation of mTOR complex 2","volume":"28","author":"Huang","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"2026061209213089900_bib37","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1101\/gad.1110003","article-title":"Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling","volume":"17","author":"Inoki","year":"2003","journal-title":"Genes Dev."},{"key":"2026061209213089900_bib38","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.2337\/diabetes.53.11.2748","article-title":"regulation of peroxisome proliferator-activated receptor-gamma activity by mammalian target of rapamycin and amino acids in adipogenesis","volume":"53","author":"Kim","year":"2004","journal-title":"Diabetes."},{"key":"2026061209213089900_bib39","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2016.119","article-title":"ROS homeostasis and metabolism: a critical liaison for cancer therapy","volume":"48","author":"Kim","year":"2016","journal-title":"Exp. Mol. Med."},{"key":"2026061209213089900_bib40","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis","volume":"363","author":"Krueger","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"2026061209213089900_bib41","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nature13393","article-title":"Targeting transcription regulation in cancer with a covalent CDK7 inhibitor","volume":"511","author":"Kwiatkowski","year":"2014","journal-title":"Nature."},{"key":"2026061209213089900_bib42","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1158\/0008-5472.CAN-13-1915","article-title":"HuR posttranscriptionally regulates WEE1: implications for the DNA damage response in pancreatic cancer cells","volume":"74","author":"Lal","year":"2014","journal-title":"Cancer Res."},{"key":"2026061209213089900_bib43","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/nsmb.2399","article-title":"Cyclin-dependent kinase control of the initiation-to-elongation switch of RNA polymerase II","volume":"19","author":"Larochelle","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2026061209213089900_bib44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1084\/jem.20131080","article-title":"Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells","volume":"211","author":"Li","year":"2014","journal-title":"J. Exp. Med."},{"key":"2026061209213089900_bib45","doi-asserted-by":"publisher","first-page":"E21","DOI":"10.1073\/pnas.1417015112","article-title":"Synthetic lethality of combined glutaminase and Hsp90 inhibition in mTORC1-driven tumor cells","volume":"112","author":"Li","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2026061209213089900_bib46","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.1073\/pnas.0914798107","article-title":"Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis","volume":"107","author":"Li","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2026061209213089900_bib47","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3109\/10715761003667554","article-title":"Reactive oxygen species in cancer","volume":"44","author":"Liou","year":"2010","journal-title":"Free Radic. Res."},{"key":"2026061209213089900_bib48","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"2026061209213089900_bib49","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","article-title":"Selective inhibition of tumor oncogenes by disruption of super-enhancers","volume":"153","author":"Lov\u00e9n","year":"2013","journal-title":"Cell."},{"key":"2026061209213089900_bib50","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14806\/ej.17.1.200","article-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads","volume":"17","author":"Martin","year":"2011","journal-title":"EMBnet.journal"},{"key":"2026061209213089900_bib51","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":"Efficacy and safety of sirolimus in lymphangioleiomyomatosis","volume":"364","author":"McCormack","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"2026061209213089900_bib52","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nature10602","article-title":"Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia","volume":"481","author":"Metallo","year":"2011","journal-title":"Nature."},{"key":"2026061209213089900_bib53","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.semcdb.2017.05.023","article-title":"ROS signalling in the biology of cancer","volume":"80","author":"Moloney","year":"2018","journal-title":"Semin. Cell Dev. Biol."},{"key":"2026061209213089900_bib54","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1006\/mcne.2002.1184","article-title":"Tsc2 null murine neuroepithelial cells are a model for human tuber giant cells, and show activation of an mTOR pathway","volume":"21","author":"Onda","year":"2002","journal-title":"Mol. Cell. Neurosci."},{"key":"2026061209213089900_bib55","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1158\/1541-7786.MCR-13-0258-T","article-title":"Autophagy-dependent metabolic reprogramming sensitizes TSC2-deficient cells to the antimetabolite 6-aminonicotinamide","volume":"12","author":"Parkhitko","year":"2014","journal-title":"Mol. Cancer Res."},{"key":"2026061209213089900_bib56","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.1016\/j.celrep.2018.06.032","article-title":"The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma","volume":"23","author":"Ricketts","year":"2018","journal-title":"Cell Reports."},{"key":"2026061209213089900_bib57","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/pro.3424","article-title":"The essential and multifunctional TFIIH complex","volume":"27","author":"Rimel","year":"2018","journal-title":"Protein Sci."},{"key":"2026061209213089900_bib58","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","article-title":"Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer","volume":"171","author":"Robertson","year":"2017","journal-title":"Cell."},{"key":"2026061209213089900_bib59","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/emboj.2012.32","article-title":"A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB","volume":"31","author":"Settembre","year":"2012","journal-title":"EMBO J."},{"key":"2026061209213089900_bib60","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1021\/acschembio.6b00651","article-title":"Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors","volume":"11","author":"Singh","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"2026061209213089900_bib61","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/1485283","article-title":"Reactive Oxygen Species-Mediated Mechanisms of Action of Targeted Cancer Therapy","volume":"2017","author":"Teppo","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"2026061209213089900_bib62","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1089\/ars.2017.7342","article-title":"Transcriptional Regulation by Nrf2","volume":"29","author":"Tonelli","year":"2018","journal-title":"Antioxid. Redox Signal."},{"key":"2026061209213089900_bib63","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrd2803","article-title":"Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?","volume":"8","author":"Trachootham","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"2026061209213089900_bib64","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.ccell.2017.09.013","article-title":"mTORC1 Couples Nucleotide Synthesis to Nucleotide Demand Resulting in a Targetable Metabolic Vulnerability","volume":"32","author":"Valvezan","year":"2017","journal-title":"Cancer Cell."},{"key":"2026061209213089900_bib65","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.277.5327.805","article-title":"Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34","volume":"277","author":"van Slegtenhorst","year":"1997","journal-title":"Science."},{"key":"2026061209213089900_bib66","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.mito.2013.01.008","article-title":"Mitochondrial metabolism of reactive oxygen species","volume":"13","author":"Venditti","year":"2013","journal-title":"Mitochondrion."},{"key":"2026061209213089900_bib67","doi-asserted-by":"publisher","first-page":"15201","DOI":"10.1073\/pnas.1103746108","article-title":"The mammalian target of rapamycin regulates cholesterol biosynthetic gene expression and exhibits a rapamycin-resistant transcriptional profile","volume":"108","author":"Wang","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2026061209213089900_bib68","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.cell.2015.08.063","article-title":"CDK7-dependent transcriptional addiction in triple-negative breast cancer","volume":"163","author":"Wang","year":"2015","journal-title":"Cell."},{"key":"2026061209213089900_bib69","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.cell.2013.03.035","article-title":"Master transcription factors and mediator establish super-enhancers at key cell identity genes","volume":"153","author":"Whyte","year":"2013","journal-title":"Cell."},{"key":"2026061209213089900_bib70","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1479-5876-8-14","article-title":"Comparison of three rapamycin dosing schedules in A\/J Tsc2+\/- mice and improved survival with angiogenesis inhibitor or asparaginase treatment in mice with subcutaneous tuberous sclerosis related tumors","volume":"8","author":"Woodrum","year":"2010","journal-title":"J. Transl. Med."},{"key":"2026061209213089900_bib71","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cmet.2011.06.002","article-title":"Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways","volume":"14","author":"Yecies","year":"2011","journal-title":"Cell Metab."},{"key":"2026061209213089900_bib72","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0960-9822(99)00268-7","article-title":"Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR","volume":"10","author":"Yokogami","year":"2000","journal-title":"Curr. Biol."},{"key":"2026061209213089900_bib73","doi-asserted-by":"publisher","first-page":"L694","DOI":"10.1152\/ajplung.00204.2003","article-title":"Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways","volume":"286","author":"Yu","year":"2004","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"2026061209213089900_bib74","doi-asserted-by":"publisher","first-page":"4460","DOI":"10.1158\/0008-5472.CAN-17-0015","article-title":"Posttranscriptional Upregulation of IDH1 by HuR Establishes a Powerful Survival Phenotype in Pancreatic Cancer Cells","volume":"77","author":"Zarei","year":"2017","journal-title":"Cancer Res."},{"key":"2026061209213089900_bib75","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1172\/JCI200317222","article-title":"Loss of Tsc1\/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR","volume":"112","author":"Zhang","year":"2003","journal-title":"J. Clin. Invest."},{"key":"2026061209213089900_bib76","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/nature13492","article-title":"Coordinated regulation of protein synthesis and degradation by mTORC1","volume":"513","author":"Zhang","year":"2014","journal-title":"Nature."},{"key":"2026061209213089900_bib77","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1158\/1535-7163.MCT-17-0078","article-title":"Preclinical Efficacy and Molecular Mechanism of Targeting CDK7-Dependent Transcriptional Addiction in Ovarian Cancer","volume":"16","author":"Zhang","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"2026061209213089900_bib78","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1146\/annurev-biochem-052610-095910","article-title":"RNA polymerase II elongation control","volume":"81","author":"Zhou","year":"2012","journal-title":"Annu. Rev. Biochem."}],"updated-by":[{"DOI":"10.1084\/jem.2019025105292026r","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000}},{"DOI":"10.1084\/jem.2019025105292026r","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"record-id":"71636"}],"container-title":["Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/216\/11\/2635\/1760655\/jem_20190251.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/216\/11\/2635\/1760655\/jem_20190251.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T13:21:40Z","timestamp":1781270500000},"score":1,"resource":{"primary":{"URL":"https:\/\/rupress.org\/jem\/article\/216\/11\/2635\/120616\/RETRACTED-Tumors-with-TSC-mutations-are-sensitive"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,10]]},"references-count":78,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11,4]]}},"URL":"https:\/\/doi.org\/10.1084\/jem.20190251","relation":{},"ISSN":["0022-1007","1540-9538"],"issn-type":[{"value":"0022-1007","type":"print"},{"value":"1540-9538","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,10]]}}}